Preoperative Glucagon-Like Peptide-1 Agonist Use Is Associated With Decreased Complications Compared to Bariatric Surgery Following Primary Total Hip Arthroplasty
George Bcharah(Mayo Clinic Hospital), Joshua S. Bingham(Mayo Clinic Hospital), Henry D. Clarke(Mayo Clinic Hospital), Mark J. Spangehl(Mayo Clinic Hospital), Saad Tarabichi(Mayo Clinic Hospital), Zaid Elsabbagh(Apple (Israel)), Austin E. Wininger(Mayo Clinic Hospital), Zachary K. Christopher, Jens T. Verhey(Mayo Clinic Hospital)
Cited by 0
Related Papers
Does use of glucagon-like peptide-1 agonists increase perioperative complications in patients undergoing shoulder arthroplasty?
|Journal of Shoulder and Elbow Surgery|2024|24
An Evidence-Based Clinical Prediction Algorithm for the Musculoskeletal Infection Society Minor Criteria
|The Journal of Arthroplasty|2018|17
Clonal Hematopoiesis in Patients With Neuroendocrine Tumor Treated With Lutetium-177 and the Risk of Thrombocytopenia: A Prospective Study
|JCO Precision Oncology|2024|5
Clinical Outcomes and Molecular Profiling of Pancreatic Acinar Cell Carcinoma: A Retrospective Study
|JCO Precision Oncology|2025|5
The associations of comorbidities with healthcare utilization among patients undergoing total shoulder arthroplasty
|Seminars in Arthroplasty JSES|2025|2